| Financial Year |
March 31 2023 |
| Monetary Funds |
3,529,280,000.00 |
| Held-for-trading Financial Assets |
1,712,000.00 |
| Notes Receivable |
74,399,000.00 |
| Accounts Receivable |
9,569,469,000.00 |
| Advances to Suppliers |
377,674,000.00 |
| Other Receivables |
1,660,608,000.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
17,264,564,000.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,213,989,000.00 |
| Total Current Assets |
34,000,935,000.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
54,960,000.00 |
| Long-term Equity Investment |
26,574,000.00 |
| Investment Properties |
23,372,000.00 |
| Fixed Assetes |
9,225,204,000.00 |
| Under-construction Projects |
2,796,572,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,306,606,000.00 |
| R&D expenses |
-- |
| Goodwill |
4,856,324,000.00 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
1,489,588,000.00 |
| Other Non-Current Assets |
526,007,000.00 |
| Sub-Total of Non-Current Assets |
25,009,869,000.00 |
| Total Assets |
59,010,804,000.00 |
| Short-Term Loans |
6,713,822,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
525,141,000.00 |
| Accounts Payable |
6,408,409,000.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,236,838,000.00 |
| Taxes Payable |
599,951,000.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,711,473,000.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,353,337,000.00 |
| Other Current Liabilities |
623,098,000.00 |
| Sub-Total of Current Liabilities |
22,220,580,000.00 |
| Long-term Loans |
3,520,806,000.00 |
| Bonds Payable |
7,141,510,000.00 |
| Long-Term Accounts Payable |
103,886,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
278,235,000.00 |
| Deferred Income Tax Liabilities |
311,008,000.00 |
| Other Non-Current Liabilities |
1,271,258,000.00 |
| Sub-Total of Non-Current Liabilities |
13,847,005,000.00 |
| Total Liabilities |
36,067,585,000.00 |
| Paid-In Capital(Or Share Stock) |
2,329,812,000.00 |
| Capital Surplus |
12,945,837,000.00 |
| Surplus Reserve |
242,498,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
6,539,185,000.00 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
22,943,219,000.00 |
| Owner's Equity（Stockholder's Equity） |
22,943,219,000.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
59,010,804,000.00 |
